G9229 HCPCS Reimbursement & Policy Benchmarks

HCPCS Level II code G9229 indicates that screening results for chlamydia, gonorrhea, and syphilis were not documented in the medical record, with patient refusal as the sole permitted exception. This code matters nationally because accurate documentation of sexually transmitted infection (STI) screening is critical for public health surveillance, quality measurement, and continuity of care; missing results can affect reporting, follow-up, and quality metrics.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage considerations and common operational implications when G9229 is reported.

Readers will learn what G9229 represents in clinical documentation and billing workflows, the typical settings where the code is applied, and how its use intersects with quality measurement and recordkeeping. Benchmarks and policy updates are summarized where available, along with clinical context about the importance of documenting STI screening results. Data not provided in the input are noted as unavailable. The content focuses on national implications for documentation, billing, and quality reporting related to absent STI screening results.

Billing Code Overview

HCPCS Level II code G9229 denotes that screening results for chlamydia, gonorrhea, and syphilis were not documented, with patient refusal identified as the only allowed exception. The code is used to capture instances where recommended STI screening results are absent from the medical record despite screening being indicated.

Service Type: Preventive/Screening documentation error

Typical Site of Service: Outpatient ambulatory settings, including primary care clinics, sexual health clinics, community health centers, and other ambulatory care locations where STI screening would normally be performed and documented.

Data not available in the input.

Clinical Context

Scenario: A 22-year-old sexually active female presents to a primary care clinic for an annual well visit and requests routine sexually transmitted infection screening. The clinician documents counseling about screening for chlamydia, gonorrhea, and syphilis and orders nucleic acid amplification testing (NAAT) for chlamydia and gonorrhea and serology for syphilis. The patient declines specimen collection and testing after counseling; the refusal is documented in the medical record. The clinic encounters billing situation for screening results not documented in the chart despite ordered testing; the only documented permissible reason for absence of results is patient refusal.

Clinical workflow:

Patient encounter and sexual history obtained by primary care provider or sexual health clinician.
Screening tests are discussed and orders placed for Chlamydia and Gonorrhea NAAT and Syphilis serology (treponemal and/or non-treponemal tests).
If the patient consents, specimens are collected on-site or sent to a laboratory; results are entered into the chart and managed per positive/negative findings.
If the patient refuses testing, the refusal is documented in the chart, and no laboratory result will appear; billing for the encounter may require use of a code indicating screening results are not documented with patient refusal as the only allowed exception, corresponding to G9229.
Typical sites of service: outpatient primary care clinics, sexually transmitted infection clinics, community health centers, college health services, and family planning clinics.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when the service required substantially greater effort or complexity than typical for the visit (document rationale).

23 | Unusual anesthesia | Use if an unusual, medically necessary anesthesia was provided for collection not typical for the setting.

52 | Reduced services | Use when screening was initiated but not completed and services were partially performed.

53 | Discontinued procedure | Use when testing process was started but discontinued before completion for reasons other than patient refusal.

54 | Surgical care only | Not typically applicable; may be used if procedural aspects are billed separately by another provider.

55 | Postoperative management only | Not typically applicable to screening; rare use only if postoperative follow-up is billed separate from index visit.

56 | Preoperative management only | Not typically applicable; used when only pre-op services are furnished.

62 | Two surgeons | Rarely applicable; use when two surgeons are required for a procedure related to STI complications.

AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Uncommon for screening; may apply in clinics where advanced practice clinicians assist with procedures.

CO | Routine home health care | Use in limited contexts where services are provided under CO taxonomy in home health settings.

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary setting for STI screening and counseling.

208000000X | Internal Medicine | Adult primary care where STI screening is performed.

207R00000X | Obstetrics & Gynecology | Common provider for screening in reproductive-age women and prenatal care.

363L00000X | Public Health & General Preventive Medicine | Used by sexual health and public health clinics providing population screening.

367A00000X | Infectious Disease | Consultative specialty when STI diagnosis or management is complex.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z11.3`	Encounter for screening for infections with a predominantly sexual mode of transmission	Used for asymptomatic individuals presenting for STI screening including chlamydia, gonorrhea, and syphilis.

Z20.2 | Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission | Used when patient reports exposure and screening is considered; testing may be ordered or refused.

A54.00 | Gonococcal infection, unspecified site | Relevant when screening identifies gonorrhea; initially considered in differential when screening is indicated.

A56.00 | Chlamydial infection, unspecified site | Relevant when screening identifies chlamydia; used when infection is confirmed.

A50.9 | Congenital syphilis, unspecified | Relevant in contexts of prenatal screening for syphilis though not directly for adult screening refusal coding.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87491`	Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique, direct probe not applicable	Common laboratory test performed when chlamydia screening is completed; would produce results that may be absent if patient refuses testing.

87591 | Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique, direct probe not applicable | Gonorrhea NAAT commonly ordered alongside chlamydia testing; results are part of the screening bundle.

86780 | Treponema pallidum antibody, direct treponemal test (e.g., FTA-ABS, TP-PA) | Serologic treponemal testing for syphilis performed if syphilis screening is completed.

86592 | Syphilis non-treponemal test (e.g., RPR) | Non-treponemal screening/monitoring test that may be ordered with treponemal tests.

99213 | Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes | Typical E/M code used for the visit in which STI screening is discussed and either performed or refused; documents counseling and refusal when applicable.

OpenPayer

Summary & Overview

HCPCS G9229: Chlamydia, Gonorrhea, and Syphilis Screening Results Not Documented